Successful milestones

  • De- and recellularization of a blood vessel (a vein without valves) using bone-marrow stem cells
  • Developing solutions and media needed to facilitate the de- and recellularization process
  • Adaptation of the de-/recellularization technique to veins with valves
  • Development of a refined procedure for recellularizing blood vessels, which is now ready for scale up in a regulatory correct environment (GMP)
  • Development of a technique for isolation of stem cells from peripheral whole blood
  • Successful transplantation of tissue engineered blood vessels to 3 pedriatric patients

Future milestones

  • Further development of the technique of using peripheral blood stem cells
  • Applying the technology to develop also tissue-engineered arteries
  • GMP accreditation of the production of media and solutions for the de- and recellularization of blood vessels
  • GMP accreditation of the process for developing recellularized blood vessels
  • Performing a clinical study with Personalized Tissue Engineered Veins (P-TEV)
  • Establishing a regulatory roadmap
  • Scaling production of tissue-engineered veins and arteries
Rapid test for covid1ç